Lamotrigine and Injection site abscess - a phase IV clinical study of FDA data

Summary:

Injection site abscess is found among people who take Lamotrigine, especially for people who are female, 10-19 old.

The phase IV clinical study analyzes which people take Lamotrigine and have Injection site abscess. It is created by eHealthMe based on reports of 61,601 people who have side effects when taking Lamotrigine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 30, 2022

61,601 people reported to have side effects when taking Lamotrigine.
Among them, 6 people (0.01%) have Injection site abscess.


What is Lamotrigine?

Lamotrigine has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 64,928 Lamotrigine users for its effectiveness, alternative drugs and more.

What is Injection site abscess?

Injection site abscess is found to be associated with 607 drugs and 327 conditions by eHealthMe.

Number of Lamotrigine and Injection site abscess reports submitted per year:

Could Lamotrigine cause Injection site abscess?

Gender of people who have Injection site abscess when taking Lamotrigine *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Injection site abscess when taking Lamotrigine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 40 %
  • 20-29: 0.0 %
  • 30-39: 20 %
  • 40-49: 20 %
  • 50-59: 20 %
  • 60+: 0.0 %

Common drugs people take besides Lamotrigine *:

  1. Vivitrol: 2 people, 33.33%
  2. Zolpidem: 1 person, 16.67%
  3. Singulair: 1 person, 16.67%
  4. Sertraline: 1 person, 16.67%
  5. Pantoprazole: 1 person, 16.67%
  6. Invega Trinza: 1 person, 16.67%
  7. Invega Sustenna: 1 person, 16.67%
  8. Flector: 1 person, 16.67%
  9. Clobazam: 1 person, 16.67%
  10. Betamethasone Sodium Phosphate: 1 person, 16.67%

Common side effects people have besides Injection site abscess *:

  1. Injection Site Pain: 5 people, 83.33%
  2. Injection Site Mass: 4 people, 66.67%
  3. Injection Site Warmth: 3 people, 50.00%
  4. Injection Site Reaction: 3 people, 50.00%
  5. Malaise (a feeling of general discomfort or uneasiness): 2 people, 33.33%
  6. Injection Site Infection: 2 people, 33.33%
  7. Injection Site Necrosis (death of body tissue at injection site): 1 person, 16.67%
  8. Injection Site Cellulitis (injection site inflammation): 1 person, 16.67%
  9. Injection Site Erythema (redness at injection site): 1 person, 16.67%
  10. Injection Site Induration: 1 person, 16.67%

Common conditions people have *:

  1. Drug Dependence: 2 people, 33.33%
  2. Tendon Disorder (disease of tendon): 1 person, 16.67%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 16.67%
  4. Depression: 1 person, 16.67%
  5. Alcoholism (problems with alcohol): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lamotrigine and have Injection site abscess?

Check whether Injection site abscess is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Injection site abscess and when was it recovered:

Expand to all the drugs that have ingredients of lamotrigine:

Alternative drugs to, pros and cons of Lamotrigine:

Common Lamotrigine side effects:

Browse all side effects of Lamotrigine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Injection site abscess treatments and more:

COVID vaccines that are related to Injection site abscess:

Common drugs associated with Injection site abscess:

All the drugs that are associated with Injection site abscess:

Common conditions associated with Injection site abscess:

All the conditions that are associated with Injection site abscess:

How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamotrigine) and Lamotrigine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: